GlassScriptPhysician profile
Jon Forrest Jimison
NPI 1467413716
$1,034.45
in general payments reported to CMS, 2019-2025
18 companies · $418 in 2025
The $418 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.73 · 2022: $90.95 · 2023: $289 · 2024: $218 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $496.92 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Metrx System |
| Astrazeneca Pharmaceuticals LP | $69.62 | 2023-2024 | Andexxa |
| Centinel Spine, LLC | $63.37 | 2025 | Prodisc C Vivo |
| Averitas Pharma INC. | $60.91 | 2023-2024 | Qutenza |
| Saluda Medical Americas, INC. | $59.72 | 2023-2024 | Evoke, Evoke Scs |
| Depuy Synthes Sales INC. | $40.13 | 2025 | |
| Zimmer Biomet Holdings, INC. | $30.13 | 2023 | Mobi-C |
| Convatec INC. | $26.25 | 2023 | |
| Si-Bone, INC. | $23.34 | 2023 | |
| Baxter Healthcare | $23.16 | 2025 | Floseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.33 | 2024 | Relistor |
| Solventum Corporation | $18.14 | 2024 | Ioban 2, V.A.C. Veraflo Cleanse Choice, Prevena |
| Aesculap, INC. | $18.12 | 2023 | Aesculap |
| Kls-Martin L.P. | $18.01 | 2023 | |
| Livanova USA, INC. | $17.73 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medexus Pharma, INC. | $17.29 | 2022 | |
| Stryker Corporation | $16.52 | 2023 | Spinejack |
| Chiesi USA, INC. | $14.76 | 2025 | Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Jimison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.